Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
Globenewswire· 2026-02-27 21:05
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced it is voluntarily pausing the Phase 3 Hunger Elimination or Reduction Objective (HERO) trial. The HERO trial is a Phase 3 randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ARD- ...
Precipitate Signs Drill Contract and Conducts Drill Site Preparations in Advance of Drilling Newly Identified Target at Pueblo Grande Project
TMX Newsfile· 2026-02-27 21:05
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Precipitate Gold Corp. (TSXV: PRG) (OTCQB: PREIF) (the "Company" or "Precipitate") is pleased to announce that it has completed improvements to existing property access routes and commenced preparations of new drill site locations within the Pueblo Grande Norte Zone of the Company's 100% owned Pueblo Grande Project ("Pueblo Grande" or the "Project") in central Dominican Republic. See photos below. In addition, the Company has signed a dril ...
Rocket (RKT) AI Push Continues With Redfin ChatGPT App Launch
Yahoo Finance· 2026-02-27 21:04
Rocket Companies Inc. (NYSE:RKT) is one of 15 stocks with the biggest hedge fund momentum, after gaining 36 hedge fund holders during the fourth quarter of 2025. On February 6, Rocket Companies Inc.’s (NYSE:RKT) real estate brokerage unit, Redfin, launched a new ChatGPT app that allows users to search for homes and access market data through conversational AI. The integration enables home searchers to ask specific housing questions and refine their criteria through natural conversation rather than repeated ...
Alphabet (GOOGL) Secures Power Deals with AES, Xcel for Data Centers
Insider Monkey· 2026-02-27 21:04
Core Insights - Generative AI is viewed as a transformative technology by Amazon's CEO Andy Jassy, indicating its potential to significantly enhance customer experiences across the company [1] - Elon Musk predicts that by 2040, humanoid robots could create a market worth $250 trillion, representing a major shift in the global economy driven by AI innovation [2][3] - Major firms like PwC and McKinsey acknowledge the multi-trillion-dollar potential of AI, suggesting a broad consensus on its economic impact [3] Company and Industry Analysis - A breakthrough in AI technology is redefining work, learning, and creativity, leading to increased interest from hedge funds and top investors [4] - There is speculation about an under-owned company that may play a crucial role in the AI revolution, with its technology posing a threat to competitors [4][6] - Prominent figures in technology and investment, including Bill Gates and Warren Buffett, recognize AI as a significant advancement with the potential for substantial social benefits [8]
Analyst Optimistic on Terns (TERN) Citing Possible $4.8B Market for Upcoming Leukemia Drug
Yahoo Finance· 2026-02-27 21:04
Terns Pharmaceuticals Inc. (NASDAQ:TERN) is one of 15 stocks with the biggest hedge fund momentum, after gaining 42 hedge fund holders during the fourth quarter of 2025. On February 9, Leerink Partners initiated coverage on Terns Pharmaceuticals Inc. (NASDAQ:TERN) with an Outperform rating and a price target of $58. Leerink Partners noted that TERN-701, Terns Pharmaceuticals Inc. (NASDAQ:TERN)’s next-generation allosteric inhibitor being developed for chronic myeloid leukemia, addresses a market with est ...
Amazon.com (AMZN) Data Center Push Continues with $12B Investment in Louisiana
Yahoo Finance· 2026-02-27 21:04
Amazon.com Inc. (NASDAQ:AMZN) is one of 15 stocks with the biggest hedge fund momentum, after gaining 46 hedge fund holders during the fourth quarter of 2025. On February 23, Amazon.com Inc. (NASDAQ:AMZN) announced plans to invest $12B in northwest Louisiana to build data center campuses that will support cloud computing technologies. The online retailer said the data center buildout in northwest Louisiana will create 540 full-time jobs, as well as additional jobs to support the facilities, such as electri ...
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Globenewswire· 2026-02-27 21:03
TORONTO and HAIFA, Israel, Feb. 27, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, announced today its participation in two international conferences taking place in March 2026. Dr. Lior Shaltiel, PhD, Chief Executive Officer of NurExone, commented, “Engaging with scientific, industry, and investor audiences is a core part of our strategy, and March includes two ...
SPMD: It's Time To Ride The Long-Lasting Momentum In Mid Caps
Seeking Alpha· 2026-02-27 21:02
Core Insights - The State Street SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) is outperforming the S&P 500 in 2026, driven by factors such as rate cuts, economic stability, and earnings growth potential [1] Group 1: Performance Analysis - SPMD's price upside is attributed to favorable economic conditions including rate cuts and stability [1] - The mid-cap category is expected to continue its upward trend, indicating strong performance relative to larger indices [1] Group 2: Analyst Perspective - The analysis emphasizes a fundamental and technical approach to forecasting market trends, focusing on both short- and long-term investment horizons [1]
Nutrien: Bearish Outlook For 2026 Due To Fertilizer Macro (Rating Downgrade)
Seeking Alpha· 2026-02-27 21:02
Core Viewpoint - The article discusses the investment position of the author in YARIY shares, indicating a beneficial long position through various means such as stock ownership and derivatives [1]. Group 1 - The author expresses personal opinions regarding the investment in YARIY and clarifies that no compensation is received for the article, aside from Seeking Alpha [1]. - The article emphasizes that it should not be considered financial advice, as the author is not a licensed financial advisor [2]. - It highlights the importance of due diligence and research by investors before making any investment decisions, particularly in high-risk trading styles [2]. Group 2 - The article notes that past performance does not guarantee future results, and no specific investment recommendations are made [3]. - It mentions that the views expressed may not reflect those of Seeking Alpha as a whole, indicating a diversity of opinions among analysts [3]. - The article clarifies that the authors are third-party contributors, which may include both professional and individual investors without formal licensing [3].
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
Globenewswire· 2026-02-27 21:01
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company’s corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast wi ...